PULMONX CORPORATION Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- PULMONX CORPORATION payments for repurchase of common stock for the quarter ending 2022-12-31 was $27.00K.
- PULMONX CORPORATION payments for repurchase of common stock for the quarter ending 2022-09-30 was $0.00.
- PULMONX CORPORATION payments for repurchase of common stock for the quarter ending 2022-06-30 was $0.00.
- PULMONX CORPORATION payments for repurchase of common stock for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- PULMONX CORPORATION payments for repurchase of common stock for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- PULMONX CORPORATION payments for repurchase of common stock for fiscal 2022 was $27.00K, a 3.85% increase from fiscal 2021.
- PULMONX CORPORATION payments for repurchase of common stock for fiscal 2021 was $26.00K, a 23.81% increase from fiscal 2020.
- PULMONX CORPORATION payments for repurchase of common stock for fiscal 2020 was $21.00K, a 75.00% increase from fiscal 2019.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-27 | |
| 2022-12-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $27.00K 10-K · filed 2024-02-27 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-09 | $0.00 derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | $26.00K 10-K · filed 2023-03-01 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $26.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $47.00K derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $26.00K 10-Q · filed 2022-05-09 | $47.00K derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $21.00K 10-K · filed 2022-03-01 |
| 2020-09-30 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $21.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-12 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $12.00K 10-K · filed 2021-03-15 |
| 2018-12-31 | $0.00 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |